M. Basaran Et Al. , "Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.," American journal of clinical oncology , vol.24, no.6, pp.570-5, 2001
Basaran, M. Et Al. 2001. Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.. American journal of clinical oncology , vol.24, no.6 , 570-5.
Basaran, M., Bavbek, E., Sakar, B., Eralp, Y., Alici, S., Tas, F., ... Yaman, F.(2001). Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.. American journal of clinical oncology , vol.24, no.6, 570-5.
Basaran, M Et Al. "Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.," American journal of clinical oncology , vol.24, no.6, 570-5, 2001
Basaran, M Et Al. "Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.." American journal of clinical oncology , vol.24, no.6, pp.570-5, 2001
Basaran, M. Et Al. (2001) . "Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.." American journal of clinical oncology , vol.24, no.6, pp.570-5.
@article{article, author={M Basaran Et Al. }, title={Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.}, journal={American journal of clinical oncology}, year=2001, pages={570-5} }